Jagsonpal Pharmaceuticals Ltd.

Jagsonpal Pharmaceuticals Ltd - Outcome of AGM

Jagsonpal Pharmaceuticals Ltd - Revised Book Closure for Dividend & AGM

Jagsonpal Pharmaceuticals Ltd - Fixes Book Closure for Dividend & AGM

AGM

/Book Closure

Updates

Jagsonpal Pharmaceuticals Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from...

Statement Of Investor Complaints For The Quarter Ended June 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...

Shareholding for the Period Ended June 30, 2018

Jagsonpal Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2018. For more details, kindly Click here

Reply to Clarification- Financial results

The Exchange had sought clarification from Jagsonpal Pharmaceuticals Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing ...

Board Meeting-Outcome of Board Meeting

Outcome of the meeting of the Board of Directors held on 30.05.2018.

Resuts-Finaancial Year Ended March, 31 2018

Please find enclosed the audited financial results for the year ended 31.03.2018

Dividend

Jagsonpal Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 30, 2018, recommended Final Dividend @ ...

Financial Result Updates

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.

Outcome of Board Meeting

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2018.

SUBJECT : NOTICE FOR BOARD MEETING TO CONSIDER Audited FINANCIAL RESULTS FOR THE QUARTER / YEAR ENDED 31.03.2018

Dear Sir, Pursuant to Regulation 29 read with Regulation 47 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby g...

Compliance Under Regulation 40 (10) Certificate For Transfer / Transmission / Transposition For The Half Year Ended 31.03.2018

SUBJECT : CERTIFICATE UNDER REGULATION 40 (9) OF LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENT) REGULATIONS, 2015. (SCRIP CODE : 507789) Sir/Madam, I...

Announcement under Regulation 30 (LODR)-Newspaper Publication

JPL/SEC/STOCK-CORR-2013-2014 Date : April 12th, 2018 The Manager - Listing Agreement The Bombay Stock Exchange Ltd. Pherojbhoy Jeejeebhoy Tower Dalal ...

Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sir/Madam, Please find enclosed copies of the notice given to the shareholders regarding transfer of shares to the Investor Education and Protect...

Updates

Jagsonpal Pharmaceuticals Limited has informed the Exchange regarding 'Dear Sir/Madam,Please find enclosed copies of the notice given to the sharehold...

Disc. under Reg.30 of SEBI (SAST) Reg.2011

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition...

Statement Of Investor Complaints For The Quarter Ended March 2018 (Revised)

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...

Statement Of Investor Complaints For The Quarter Ended March 2018

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disp...

Announcement under Regulation 30 (LODR)-Acquisition

Sir, Please find attached herewith information under Regulation 30(1) and 30(2) of SEBI (substantial Acquisition of Shares and takeover. You are reque...

Disc. under Reg.30 of SEBI (SAST) Reg.2011

Jagsonpal Pharmaceuticals Limited has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition...